Objective： To prospectively evaluate the feasibility, safety and efficacy of the percutaneous pedicle screw fixation through the pedicle of fractured vertebra in the treatment of type A thoracolumbar fractures using ...Objective： To prospectively evaluate the feasibility, safety and efficacy of the percutaneous pedicle screw fixation through the pedicle of fractured vertebra in the treatment of type A thoracolumbar fractures using Sextant system in the retrospective non-randomized case-control study. Methods： Atotal of 38 consecutive non-randomized patients with type A thoracolumbar fractures, which had been stabilized posteriorly from December 2006 to March 2009, were examined retrospectively more than 9 months after surgery. Twenty-one patients had been treated conventionally with open pedicle screw fixation （OPSF） and 17 patients received minimally invasive treatment with Sextant percutaneous pedicle screw fixation （SPPSF）. As a method of evaluation, the incision size, the intraoperation and post- operative volume of blood loss, operation time, postoperative hospital stay, blood transfusion, the radiological assessment of the sagittal Cobb＇s angle, vertebral body angle and vertebral body height were recorded and compared. Results： All patients were followed up for 8-24 months （average 11.6 months）. There were significant differences in the incision size, surgical blood loss, surgical draining Joss, operation time, hospital stay after operation, blood transfusion, the proportion of antalgic supplement and postoperative incisional VAS between the two groups （P〈0.05）. Mean preoperative kyphotic deformity was 16.0° and improved by 9.3° after surgery in OPSF group, but 15.2° and 10.3° respectively in SPPSF group. Mean preoperative angle of the fractured vertebral body was 15.9°and improved by 7.9° after surgery in OPSF group, but 14.9° and 6.6° respectively in SPPSF group. Mean anterior vertebral body height （% of normal） was 67.3% before surgery and 95.8% after surgery, but 69.1% and 90.1% respectively in SPPSF group. Mean posterior vertebral body height （% of normal） was 93.3% before surgery and 99.5% after surgery, but 88.9% and 93.3% respectively in SPPSF group. Among the patien展开更多
目的比较在二甲双胍基础上加用利拉鲁肽与西格列汀治疗2型糖尿病(T2DM)对血糖控制的疗效。方法将2012年11月—2014年1月收治的34例T2DM患者随机分为西格列汀组16例和利拉鲁肽组18例,西格列汀组给予西格列汀联合二甲双胍治疗,利拉鲁肽组...目的比较在二甲双胍基础上加用利拉鲁肽与西格列汀治疗2型糖尿病(T2DM)对血糖控制的疗效。方法将2012年11月—2014年1月收治的34例T2DM患者随机分为西格列汀组16例和利拉鲁肽组18例,西格列汀组给予西格列汀联合二甲双胍治疗,利拉鲁肽组给予利拉鲁肽联合二甲双胍治疗,两组均治疗16周。观察两组治疗前、后体质量指数(BMI)、空腹血糖(FBG)及餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA1c)变化情况。结果治疗16周后两组BMI、FBG及2 h PBG、HbA1c较治疗前均降低,且利拉鲁肽组BMI和FBG较西格列汀组明显降低(P<0.05,P<0.01)。两组均无低血糖发生,利拉鲁肽组发生胃肠道反应3例,西格列汀组发生1例,均自行缓解。结论西格列汀或利拉鲁肽联合盐酸二甲双胍均可有效降低糖尿病患者BMI及血糖,但利拉鲁肽能更加明显的降低FBG及BMI。展开更多
文摘Objective： To prospectively evaluate the feasibility, safety and efficacy of the percutaneous pedicle screw fixation through the pedicle of fractured vertebra in the treatment of type A thoracolumbar fractures using Sextant system in the retrospective non-randomized case-control study. Methods： Atotal of 38 consecutive non-randomized patients with type A thoracolumbar fractures, which had been stabilized posteriorly from December 2006 to March 2009, were examined retrospectively more than 9 months after surgery. Twenty-one patients had been treated conventionally with open pedicle screw fixation （OPSF） and 17 patients received minimally invasive treatment with Sextant percutaneous pedicle screw fixation （SPPSF）. As a method of evaluation, the incision size, the intraoperation and post- operative volume of blood loss, operation time, postoperative hospital stay, blood transfusion, the radiological assessment of the sagittal Cobb＇s angle, vertebral body angle and vertebral body height were recorded and compared. Results： All patients were followed up for 8-24 months （average 11.6 months）. There were significant differences in the incision size, surgical blood loss, surgical draining Joss, operation time, hospital stay after operation, blood transfusion, the proportion of antalgic supplement and postoperative incisional VAS between the two groups （P〈0.05）. Mean preoperative kyphotic deformity was 16.0° and improved by 9.3° after surgery in OPSF group, but 15.2° and 10.3° respectively in SPPSF group. Mean preoperative angle of the fractured vertebral body was 15.9°and improved by 7.9° after surgery in OPSF group, but 14.9° and 6.6° respectively in SPPSF group. Mean anterior vertebral body height （% of normal） was 67.3% before surgery and 95.8% after surgery, but 69.1% and 90.1% respectively in SPPSF group. Mean posterior vertebral body height （% of normal） was 93.3% before surgery and 99.5% after surgery, but 88.9% and 93.3% respectively in SPPSF group. Among the patien
文摘目的比较在二甲双胍基础上加用利拉鲁肽与西格列汀治疗2型糖尿病(T2DM)对血糖控制的疗效。方法将2012年11月—2014年1月收治的34例T2DM患者随机分为西格列汀组16例和利拉鲁肽组18例,西格列汀组给予西格列汀联合二甲双胍治疗,利拉鲁肽组给予利拉鲁肽联合二甲双胍治疗,两组均治疗16周。观察两组治疗前、后体质量指数(BMI)、空腹血糖(FBG)及餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA1c)变化情况。结果治疗16周后两组BMI、FBG及2 h PBG、HbA1c较治疗前均降低,且利拉鲁肽组BMI和FBG较西格列汀组明显降低(P<0.05,P<0.01)。两组均无低血糖发生,利拉鲁肽组发生胃肠道反应3例,西格列汀组发生1例,均自行缓解。结论西格列汀或利拉鲁肽联合盐酸二甲双胍均可有效降低糖尿病患者BMI及血糖,但利拉鲁肽能更加明显的降低FBG及BMI。
